Revive Therapeutics (RVV.C) provided an update on their FDA Phase III clinical trial to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate Covid-19. …
Pharmaceuticals
Novamind (NM.C) announced that their wholly-owned subsidiary, Cedar Clinical Research (CCR), has been selected by Merck to be a key research site for a clinical trial focused on treatment-resistant…
News this week that Canntab Therapeutics (PILL.C) received an Australian patent for their hard-pressed cannabis pill tech, to match those received earlier in North America, didn’t launch the stock…
Khiron Life Sciences (KHRN.V) has opened two additional satellite Zerenia clinics in Colombia following the success of its initial small format clinic in Medellin. “We are off to a…
Heritage Cannabis (CANN.C) has been granted an export license by Health Canada. The license will permit the Company to export cannabis products to Brazil marking the first-ever license granting…
Red Light Holland (TRIP.C) has completed the sale and import of the Company’s iMicrodose psychedelic truffles packs from the Netherlands to Canada. The transaction was made possible via the…
Medexus common stock reached a high of $7.70 per share due to a positive market reaction to their latest press release. At a time where the general economy and…
Aequus is a $24 million pharmaceutical company focused on developing and commercializing high quality, differentiated products….
Xphyto Therapeutics (XPHY.C) subsidiary Xphyto Therapeutics entered into an agreement with Applied Pharmaceutical Innovation for the synthesis of pharma-grade psychedelic compounds and development of standard operating procedures to attract…
Algernon Pharmaceuticals (AGN.C) has established a clinical trial program to treat stroke that uses DMT, or (N-dimethyltryptamine) today, according to a press release. The company decided to take a…